The role of parents awareness to decision on HPV vaccination in Kazakhstan.

Dilyara Kaidarova, Nadejda Nasrytdinova, Murat Kairbayev

2017

Closed access Metadata (CSL-JSON)
DOI 10.1200/jco.2017.35.15_suppl.e17008
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

e17008 Background: Despite the proven effectiveness of HPV vaccination against cancer and precancerous lesions the acceptance rates are not perfect. The goal of the study was to look how parents awareness about HPV affected decision to vaccinate their daughters. Methods: The interview was held in schools where first HPV vaccination trial program started. The survey included questions about social and economic status, HPV and HPV vaccine awareness, the source of information on HPV and decision about vaccination. The number of surveyed parents was 357. Correlation statistics and chi-square test have been used with SPSS 19 (IBM corp.). Results: 34.7±2.52% though that HPV vaccine can protect from other STI. There was significant dependability from the country region (p=0.001) and type of urban area (p=0.017). 136 respondents out of 357 agreed to vaccinate their daughters (38.1%±2.6%). The decision to vaccinate depends from age (p=0.006), sex (p= ≤0.001) and family history of cancer (р=0.001). As the main source of information about HPV vaccine parents highlighted gynaecologists (54.0±3.02%), and paediatricians (22.8±2.54%). Most belief that vaccine protects from cancer 65.4±2.46%, whereas 16.8±1.98% trust their medical caregivers. The answers of parents depends from country region (р≤0.001), urban area (р≤0.001), sex (р=0.004), education (р=0.001), religion (р≤0.001) and family history (р≤0.001). Conclusions: The acceptance rate of HPV vaccine in trial is very low, most have doubts regarding the importance of vaccinations. There is a significant room for improvement, HPV and HPV vaccination awareness programs are needed to increase the acceptance rate of the vaccine in Kazakhstan.